$106.49
-0.83-0.77%
Last update: Nov 11, 1:14 PM
Zimmer Biomet Holdings Inc
ZBHNYSE
Zimmer Biomet rose 21.3% from $88.50 to $107.32, ahead of the S&P 500's +9.8%. Its worst day was Apr 28 (−10.6%), and its low came May 11 at $79.58.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $2.42 beat the $2.39 estimate on $2.2B revenue (est. $2.2B); FY revenue guidance of $8.4B–$8.6B against the $8.6B consensus.
+1.9% · S&P 500 −0.3%
Story events cover the past 12 months · Times ET
EPS of $2.09 beat the $1.86 estimate on $2.1B revenue (est. $2.1B); FY revenue guidance of $8.4B–$8.6B against the $8.5B consensus.
−10.6%, the year's worst day, on 10M shares, the year's heaviest volume · S&P 500 −0.5%
Zimmer Biomet closed at its lowest level of the year, 10.1% below where the year started.
−3.3% · S&P 500 +0.2%
Zimmer Biomet shares fell 5.6%, while the S&P 500 rose 0.8%.
−5.6% · S&P 500 +0.8%
EPS of $2.07 beat the $2.01 estimate on $2.2B revenue (est. $2.1B); FY revenue guidance of $8.6B–$8.6B against the $8.5B consensus.
+2.5% · S&P 500 −0.2%
EPS of $1.90 beat the $1.88 estimate on $2.1B revenue (est. $2.0B); FY revenue guidance of $8.6B–$8.6B against the $8.6B consensus.
+13.5%, the year's best day · S&P 500 +1.7%
Where it ended: a close of $107.32 on Nov 10, 2026. Up next: Q4 2026 earnings on Feb 9, 2027 (EPS est. $2.49, revenue est. $2.3B).
As of the Nov 10, 2026 close
Replay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ZBH and SPY from Benzinga historical bars. Not investment advice.
